Literature DB >> 17853862

A protocol for designing siRNAs with high functionality and specificity.

Amanda Birmingham1, Emily Anderson, Kevin Sullivan, Angela Reynolds, Queta Boese, Devin Leake, Jon Karpilow, Anastasia Khvorova.   

Abstract

Effective gene silencing by the RNA interference (RNAi) pathway requires a comprehensive understanding of the elements that influence small interfering RNA (siRNA) functionality and specificity. These include (i) sequence space restrictions that define the boundaries of siRNA targeting, (ii) structural and sequence features required for efficient siRNA performance, (iii) mechanisms that underlie nonspecific gene modulation and (iv) additional features specific to the intended use (i.e., inclusion of native sugar or base chemical modifications for increased stability or specificity, vector design, etc.). Attention to each of these factors enhances siRNA performance and heightens overall confidence in the output of RNAi-mediated functional genomic studies. Here, we provide a detailed protocol explaining the methodologies used for manual and web-based design of siRNAs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17853862     DOI: 10.1038/nprot.2007.278

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  76 in total

1.  shRNA expression constructs designed directly from siRNA oligonucleotide sequences.

Authors:  Tuva Barøy; Kirsten Sørensen; Mona Mari Lindeberg; Eirik Frengen
Journal:  Mol Biotechnol       Date:  2010-06       Impact factor: 2.695

2.  Rational design of therapeutic siRNAs: minimizing off-targeting potential to improve the safety of RNAi therapy for Huntington's disease.

Authors:  Ryan L Boudreau; Ryan M Spengler; Beverly L Davidson
Journal:  Mol Ther       Date:  2011-09-27       Impact factor: 11.454

Review 3.  Advances in microRNAs: implications for gene therapists.

Authors:  Rebecca T Marquez; Anton P McCaffrey
Journal:  Hum Gene Ther       Date:  2008-01       Impact factor: 5.695

4.  Improved asymmetry prediction for short interfering RNAs.

Authors:  Amanda P Malefyt; Ming Wu; Daniel B Vocelle; Sean J Kappes; Stephen D Lindeman; Christina Chan; S Patrick Walton
Journal:  FEBS J       Date:  2014-01       Impact factor: 5.542

5.  A Molecular Approach Designed to Limit the Replication of Mature DENV2 in Host Cells.

Authors:  Ummar Raheel; Muhsin Jamal; Najam Us Sahar Sadaf Zaidi
Journal:  Viral Immunol       Date:  2015-07-08       Impact factor: 2.257

Review 6.  Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR.

Authors:  Michael Boettcher; Michael T McManus
Journal:  Mol Cell       Date:  2015-05-21       Impact factor: 17.970

7.  Strategy for a generic resistance to geminiviruses infecting tomato and papaya through in silico siRNA search.

Authors:  Sangeeta Saxena; Nidhi Singh; S A Ranade; Sunil G Babu
Journal:  Virus Genes       Date:  2011-08-06       Impact factor: 2.332

Review 8.  RNAi medicine for the brain: progresses and challenges.

Authors:  Ryan L Boudreau; Edgardo Rodríguez-Lebrón; Beverly L Davidson
Journal:  Hum Mol Genet       Date:  2011-03-31       Impact factor: 6.150

9.  Specific gene silencing using RNAi in cell culture.

Authors:  Chunxing Yang; Linghua Qiu; Zuoshang Xu
Journal:  Methods Mol Biol       Date:  2011

10.  Spink13, an epididymis-specific gene of the Kazal-type serine protease inhibitor (SPINK) family, is essential for the acrosomal integrity and male fertility.

Authors:  Li Ma; Heguo Yu; Zimei Ni; Shuanggang Hu; Wubin Ma; Chen Chu; Qiang Liu; Yonglian Zhang
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.